Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

BrandSpark, in partnership with Newsweek, is excited to present the 18th annual Best New Product Awards nominees.

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

Ferrari has spent years turning its Tailor Made program into a serious business pillar, not merely a personalization exercise ...

Obesity causes hypertension. Hypertension causes cardiovascular disease. And cardiovascular disease is the leading cause of ...

Results reveal mechanism driving high blood pressure and point toward more precise therapies targeting communication between fat and blood vessels.

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Obesity causes hypertension. Hypertension causes cardiovascular disease. And cardiovascular disease is the leading cause of ...

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; ...

SAN DIEGO, CA / ACCESS Newswire / January 21, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...